Clavulanate News
Ranbaxy Labs receives FDA nod to market amoxicillin & clavulanate
Ranbaxy Laboratories said Wednesday that its wholly owned subsidiary, Ranbaxy Pharmaceuticals (RPI), has received an approval from the US FDA to market amoxicillin and clavulanate potassium for oral suspension USP.
GSK Receives Approvable Letter for Topical Antibiotic, Altabax(TM) (retapamulin ointment), 1%
GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration has issued an approvable letter for its topical antibacterial, Altabax (retapamulin ointment), 1%, for the treatment of secondarily-infected...
Antibiotics Mostly Useless for Sinusitis
If you develop a mild sinus infection this winter -- or even a moderately severe one -- antibiotics won't necessarily speed your recovery, new research shows.
The efficacy of cefdinir in acute bacterial rhinosinusitis
Acute bacterial rhinosinusitis is a common infection resulting in substantial morbidity.
Endogenous ethanol production in a patient with chronic intestinal pseudo-obstruction and small intestinal bacterial overgrowth
The case of the gastrointestinal production of ethanol from Candida albicans and Saccharomyces cerevisiae in a Caucasian man with chronic intestinal pseudo-obstruction is reported.